...banking group. He was previously the head of the healthcare and investment banking team at Merriman Curhan Ford...

...with $221M in cash, has a "healthy cash position" (see B7). Facet Biotech Corp. (NASDAQ:FACT) Merriman Curhan Ford...

...6 million Price: $7 Shares after offering: 21.6 million Underwriters: Deutsche Bank; Piper Jaffray; Cowen; Merriman Curhan Ford...

...million and been valued at $242.2 million. Underwriters were Deutsche Bank; Piper Jaffray; Cowen; and Merriman Curhan Ford...

...million shares at $7 in an IPO underwritten by Deutsche Bank; Piper Jaffray; Cowen; and Merriman Curhan Ford...

...6 million Price: $7 Shares after offering: 21.6 million Underwriters: Deutsche Bank; Piper Jaffray; Cowen; Merriman Curhan Ford...

...& changes Company Bank Analyst Coverage Opinion Wk chg 2/26 cls Acorda Therapeutics Inc. (NASDAQ:ACOR) Merriman Curhan Ford...

...Co. (NYSE:LLY) and Shionogi & Co. Ltd. Underwriters are Deutsche Bank; Piper Jaffray; Cowen; and Merriman Curhan Ford...

...filed in September to raise up to $70 million. Deutsche Bank; Piper Jaffray; Cowen; and Merriman Curhan Ford...

...his peak U.S. sales estimate of over $600M for Dupuytren's contracture alone. Depomed Inc. (NASDAQ:DEPO) Merriman Curhan Ford...